BRITISH AMERICAN TOBACCO WKN: 916018 ISIN: GB0002875804 Forum: Aktien Thema: Hauptdiskussion
Outlook: – Global tobacco industry volume expected to be down c.2%. – c.1% revenue growth (at constant rates), as we navigate increased excise and VAT in Bangladesh and new tobacco regulations in Australia. – 1.5-2.5% adjusted profit from operations growth (adjusted for Canada, at constant rates)*, including an expected c.1.5% transactional FX headwind. – Performance expected to be second half weighted as we deploy our innovations throughout the year. – Net finance costs* expected to be around £1.8 billion (adjusted for Canada). – The impact of translational foreign exchange is expected to be broadly flat on full year adjusted profit from operations growth. – Operating cash flow conversion in excess of 90%, with gross capital expenditure in 2025 of approximately £650 million. – Continue to deleverage (adjusted for Canada) to our 2.0-2.5x adjusted net debt/adjusted EBITDA corridor by 2026. – Commitment to dividend growth in sterling terms and £900 million share buy-back.
Outlook: – Global tobacco industry volume expected to be down c.2%. – c.1% revenue growth (at constant rates), as we navigate increased excise and VAT in Bangladesh and new tobacco regulations in Australia. – 1.5-2.5% adjusted profit from operations growth (adjusted for Canada, at constant rates)*, including an expected c.1.5% transactional FX headwind. – Performance expected to be second half weighted as we deploy our innovations throughout the year. – Net finance costs* expected to be around £1.8 billion (adjusted for Canada). – The impact of translational foreign exchange is expected to be broadly flat on full year adjusted profit from operations growth. – Operating cash flow conversion in excess of 90%, with gross capital expenditure in 2025 of approximately £650 million. – Continue to deleverage (adjusted for Canada) to our 2.0-2.5x adjusted net debt/adjusted EBITDA corridor by 2026. – Commitment to dividend growth in sterling terms and £900 million share buy-back.
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | BRITISH AMERICAN TOBACCO Hauptdiskussion | ||
| 2 | BAT Diskussionsforum ohne ETON |
|
|
Thema | ||
|---|---|---|---|
| 1 | Germany 40 Prognose | +0,80 % | |
| 2 | RHEINMETALL Hauptdiskussion | -2,53 % | |
| 3 | MICRON TECHNOLOGY Hauptdiskussion | +2,33 % | |
| 4 | RENK (für normale, sachliche Kommunikation!) | -2,60 % | |
| 5 | IPO CSG | -3,81 % | |
| 6 | ZALANDO Hauptdiskussion | +0,72 % | |
| 7 | Canopy Hauptforum | -0,25 % | |
| 8 | ATOS Hauptdiskussion | +0,69 % | |
| 9 | Novo Nordisk nach Split | +2,17 % | |
| 10 | Renk und alles was dazugehört | -2,60 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | RHEINMETALL Hauptdiskussion | -2,53 % | |
| 2 | MICRON TECHNOLOGY Hauptdiskussion | +2,33 % | |
| 3 | RENK (für normale, sachliche Kommunikation!) | -2,60 % | |
| 4 | IPO CSG | -3,81 % | |
| 5 | ZALANDO Hauptdiskussion | +0,72 % | |
| 6 | Canopy Hauptforum | -0,25 % | |
| 7 | Novo Nordisk nach Split | +2,17 % | |
| 8 | ATOS Hauptdiskussion | +0,69 % | |
| 9 | Renk und alles was dazugehört | -2,60 % | |
| 10 | Investmentchancen | +0,21 % | Alle Diskussionen |